News & Updates

Project RESET, led by Prof. Roger Foo, aims to understand and prevent early cardiovascular disease by integrating clinical, biological, and digital health markers. Our team at Digital Heart Lab, NUS, is now contributing to the wearable data processing component, including time-series analysis, data harmonization, digital biomarker extraction, and machine learning for cardiovascular health.We are looking for candidates with experience in wearable or longitudinal health data, signal processing, machine learning, and strong coding skills. Please feel free to share with anyone who may be interested. 📩 Contact: lilei.sky@outlook.com

The RESET-Inspire Study aims to assess insulin resistance early by using continuous glucose monitoring (CGM) devices, understand how insulin resistance affects muscle, liver and fat, and test how food education together with the CGM may improve or reverse the condition. Currently looking for participants.

Foo Lab attends the EMBL Conference "The New Cardiobiology: Engineering, Vascular and Molecular Insights" which was held in Heidelberg, Germany.

Foo Lab attends the Cold Spring Harbor Asia conference on "From Mechanisms to Therapies: Targeting Cardiometabolic Complications in Obesity and Diabetes" which was held in Suzhou China.

Project RESET collaborated with SG Marathon Pte Ltd, this year's Standard Chartered Singapore Marathon organizers for our 3rd annual community outreach event. Outreach events such as these allow us to transform communities into active participants in the pursuit of medical breakthroughs.

Foo Lab attends the 17th Stem Cell Society Singapore Symposium, a unique symposium meant to bring together scientists across the region and the globe to share their latest research on stem cells.

Professor Roger Foo, Vice-Dean of Research at Yong Loo Lin School of Medicine, National University of Singapore, is leading a transformative shift in cardiovascular research with a distinctly Asian focus.

On 17 February 2025, Yong Loo Lin School of Medicine held its first forum dedicated to reimagining how health research can meaningfully serve the people it seeks to benefit.

Established in 1905, NUS School of Medicine has grown into a leading medical academic research-engine in Asia. With 17 departments, 10 Translational Research Programmes, and 15 Faculty Research Centres, NUS Medicine investigators drive impactful research across the span of medicine.

Project RESET successfully hosted its inaugural Townhall on August 27, 2025. The event brought together over a hundred participants, as well as commercial collaborators from Garmin, Atlantis Bioscience, and Buzud, fostering strong community engagement.

In a first, the VHRT gene discovered by researchers at the Yong Loo Lin School of Medicine, National University of Singapore, has been added to the Human Gene Nomenclature database.

Foo Lab released a comprehensive physiological review in Physiological Reviews, covering the latest advances in next-generation genome-wide association study (GWAS) methodologies for cardiovascular disease.

Foo Lab, as part of the SG100K project, co-authored a significant paper in Nature Cardiovascular Research revealing a causal link between a bile acid–associated gene and atherosclerosis using genetically edited iPSCs.

Foo Lab attended the XXV World Congress International Society for Heart Research (ISHR 2025), an internationally distinguished conference that provides a platform for basic and clinical scientists in cardiovascular health.

Dr. Mick Lee has been using CRISPR screening to dissect mechanisms of cardiomyocyte differentiation and function. NF2 is crucial to regulate Wnt signaling and the AMOT-NF2-YAP scaffold complex at adherens junctions is required for mesodermal lineage specification.

Foo Lab co-authored a bioethics opinion article evaluating Singapore's consent procedures for secondary research use of de-identified biospecimens, advocating for regulatory reforms to promote more effective biomedical research outcomes.

Foo Lab attended the Keystone Symposia Conference on "Cardiovascular Epigenetics and Gene Regulation" (C5-2024).

This study from Dr. Yike Zhu was recently published in CIRCULATION. The team leveraged in vitro cultured adult mouse cardiomyocytes and in vivo AAV9 cardiomyocyte-targeted delivery of reprogramming factors to study CM dedifferentiation.

Roger was asked to provide some inspiration for the new calendar year. "A new year with new beginnings. I've been asked to reflect. It is a wonderful time to be called to serve in the ecosystem as Vice-Dean (Research) at NUS Yong Loo Lin School of Medicine…"

Professor Roger Foo Sik Yin has been appointed as Vice-Dean (Research) at the Yong Loo Lin School of Medicine, National University of Singapore from 1 January 2024. Prior to his new appointment, he held the role of Assistant Dean (Research) at NUS Medicine since October 2019.